INS and hepatitis C virus infection: Only rarely do we see quantum leap improvements.” The breakthroughs represented by proton pump inhibitors, or by direct acting antivirals on hepatitis C, have to be set against the many small incremental changes made to both beta blockers and insulin, or in creating more effective cancer cocktails [30,31,32].